Market News & Analysis
Asia Morning: US Stocks Mixed, Biotech Sector Leads
Ming Lam May 12, 2020 10:35 AM
The Dow Jones Industrial Average slipped 109 points (-0.5%) to 24,222, the S&P 500 was little changed at 2,930, while the Nasdaq 100 rose 78 points (+0.9%) to 9,298.
Source: GAIN Capital, TradingView
Pharmaceuticals, Biotechnology & Life Sciences (+2.27%), Technology Hardware & Equipment (+1%) and Health Care Equipment & Services (+0.92%) sectors performed the best, while Banks (-3.68%), Automobiles & Components (-3.22%) and Consumer Services (-1.89%) sectors lagged behind.
Nektar Therapeutics (NKTR +9.2%), Cardinal Health (CAH +6.7%), Vertex Pharmaceuticals (VRTX +5.0%) and Gilead Sciences (GILD +4.3%) were top gainers.
On the other hand, Under Armour (UAA -9.7%), Alliance Data Systems (ADS -8.8%), Coty (COTY -8.1%) and Mosaic (MOS -5.8%) lost the most.
On the technical side, about 29.8% (25.2% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average, and 74.9% (57.2% in the prior session) were above their 20-day moving average.
Later today, April U.S. Consumer Price Index (-0.8% on month expected), government monthly budget balance (deficit of 737.0 billion dollars expected), and the National Federation of Independent Business's Small Business Optimism Index (84.0 expected) will be reported.
European stocks looked tired, with the Stoxx Europe 600 Index slipping 0.4%. Germany's DAX fell 0.7%, France's CAC dropped 1.3%, while the U.K.'s FTSE 100 was little changed.
U.S. Treasury prices eased further as investors expected an increasing supply of Treasuries. The benchmark 10-year Treasury yield advanced 4.5 basis points to 0.724%.
Spot gold price declined 4 dollars to $1,695 an ounce as U.S. dollar firmed up.
U.S. WTI crude oil futures (June) fell 2.4% to $24.14 a barrel, and Brent crude oil futures were down 4.3% to $29.63 a barrel.
On the forex front, the U.S. dollar strengthened against other major currencies. The ICE U.S. Dollar Index regained the key 100 level as it jumped 1.1% to 100.23.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.